HarbourVest, Pantheon enable $1.1bn continuation fund for QHP Capital’s Azurity Pharmaceuticals
Thursday, March 19, 2026 · first reported by AltAssets
QHP Capital has achieved a $1.1bn final close for a single-asset continuation vehicle backing portfolio company Azurity Pharmaceuticals, with support from secondaries investors HarbourVest and Pantheon. The continuation fund enables QHP to extend its investment horizon in the pharmaceutical portfolio business.
- Firm
- QHP Capital
- Also named
- Azurity Pharmaceuticals, HarbourVest, Pantheon
- Fund
- QHP Capital Azurity Pharmaceuticals Continuation Fund
- Size
- $1.1B
- Stage
- Final close
- Asset class
- Private equity, Secondaries
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 source- Apax Sets $13.5 Billion Target for Fund XIIWSJ
- Investcorp closes second North American PE fund at $1.22bnAlternatives Watch +1
- TPG Gets $10 Billion for Climate PE Fund; to Close for New CashBloomberg +2
- Antin agrees sale of majority stake in Vicinity Energy to Harrison StreetPrivate Equity Wire +3
- Ares raises $1.15bn for PE secondaries Fund IThe Secondary Brief
- Thompson Street targets $1.7bn for seventh flagship fundBuyouts Insider